Introduction

54
Nausea and vomiting are common symptoms in numerous medical conditions, including 55 advanced cancer and diabetic gastroparesis (e.g., 12, 45) , and are prominent side effects of medical 56 treatments such as cancer chemotherapy, inhalational anesthetics, and opioid analgesics (e.g., 13, 
69
The traditional stimulus for investigating the GI vagal afferent component of emesis is 70 intragastric administration of copper sulfate (CuSO 4 ), a gastric irritant (25, 50); however, its action in 71 musk shrews, the primary small animal model for emesis research, is not well defined (e.g., 17, 20, 72 26, 31, 34, 47) . Furthermore, although viral tracing techniques have been used to identify brain 73 regions that receive abdominal vagal inputs in non-emetic rodents (37), parallel studies in emetic 74 species have not been conducted. In order to assess the mechanisms of action of CuSO 4 in musk 75 shrews, we needed to identify the brain regions that receive inputs from abdominal vagal afferents in 76 this species. The aims of the current study were (1) to investigate the effects of subdiaphragmatic 77 vagotomy on CuSO 4 -induced emesis and (2) to conduct preliminary transneuronal tracing experiments to determine the anatomy of the GI-brain connection in musk shrews. We also assessed 79 completeness of vagotomy by using the gold standard from studies in the rat, retrograde transport of 80 the neuronal tracer Fluoro-Gold from the peritoneal cavity to the dorsal motor nucleus (DMN) (36).
81
The H129 strain of herpes simplex virus was used for GI-brain tracing because it is primarily 82 transported in an anterograde direction to label ascending sensory pathways from the periphery to 83 the brain (2, 4, 37, 43) . H129 virus was microinjected into the ventral surface muscle of the stomach, 84 and the centrally transported virus was localized immunohistochemically in the brain. 
MATERIALS AND METHODS
87
Animals
88
Studies included 63 adult musk shrews (> 45 days of age), offspring from breeding stock food pellets (38, 46) . Six adult male Sprague-Dawley rats (Charles River; Wilmington, MA) also were 93 used as controls for viral tracing studies. Rats were pair-housed and fed standard chow (5P76 Pro-
94
Lab IsoPro RMH3000). All animals were maintained on a 12 h light/12 h dark cycle (0700-1900 h light Study 1 included 8 sham-operated (64.5 ± 1.3 g; mean ± SEM) and 8 vagotomized (68.5 ± 1.9 102 g) male musk shrews (Taiwan strain). Shrews were anesthetized with isoflurane (2 to 3%) using an induction chamber (10 x 8.5 cm, height and diameter of cylinder) followed by a nose cone during 104 surgery. The ventral abdominal surface was shaved from the costal margin to the inguinal ligament.
105
The skin was subsequently sterilized with betadine surgical scrub and 70% isopropyl alcohol. A 106 midline 1.5 cm laparotomy incision was made and the ventral and dorsal vagal trunks running along 107 the oesphagus were bluntly dissected and transected using a thermal cautery. The peritoneum was 108 sutured (2-0 silk; Ethicon) and the skin was closed with surgical staples (7.5 x 1.75 mm, Michel).
109
Sham operations were performed using a similar approach as vagotomy surgery, except that the vagi 110 were not manipulated or lesioned. Animals were weighed daily after surgery to assess body weight 111 changes and were allowed to recover for one week before behavioral testing. After surgery,
112
ketoprofen was administered for two days (2 mg/kg, s.c., twice daily). 
116
Nicotine was made as a 2.5 mg/ml solution in sterile saline (0.15 M NaCl; subcutaneous injection = 5 117 mg/kg/2 ml) and CuSO 4 was dissolved in filtered water (Milli-Q) at a concentration of 24 mg/ml 118 (gavage injection = 120 mg/kg/5 ml). Chemical doses were based on those previously demonstrated 119 to induce peak levels of emesis (7, 40, 54) . For motion exposure, the test chambers (28 × 17 × 12 120 cm; length by width by height) were covered with a clear acrylic lid placed directly on the top and 121 were placed on a reciprocating shaker (Taitec, Double Shaker R-30, Taiyo Scientific Industrial).
122
Horizontal motion (4 cm displacement; 2 cm left and 2 cm right; 1 Hz) was applied for 10 min. These 123 motion exposure parameters were previously shown to be optimal for inducing emesis in musk 124 shrews (22). Up to four animals were tested simultaneously between 0800 and 1600 h (light phase).
125
For all tests, animals had 15 min of adaption in the test chambers (28 x 17 x 12 cm; length by width 126 by height) before injection of chemicals or the start of motion and 30 min after these manipulations.
127
All animal behavior was recorded with a digital video camera (Sony DCR-SR300 or HDR-XR550V, wide field lenses) placed above each test chamber and connected to a computer for storage (Media to 10 μl of total volume per animal; 18 shrews and 6 rats) were made using a 10 µl Hamilton syringe 162 with a 33-36 gauge needle (Nanofil; World Precision Instruments). The H129 virus stock (4.7 x 10 7 163 pfu/ml) was stored in 100 μl aliquots at -80ºC and thawed only once, immediately before use. In 164 additional shrews (n = 7), H129 virus (5 to 10 μl of total volume) was administered by dripping the 165 H129 onto the stomach (after opening the peritoneal cavity), to determine whether central viral 166 labeling in stomach-injected cases could result from leakage of virus from the stomach wall into the 167 abdominal cavity. After surgery, ketoprofen was administered for two days (2 mg/kg, s.c., twice daily).
168
All animals were weighed before surgery and daily after surgery.
169
Musk shrews were euthanized 5 or 9 days post-injection; rats were euthanized 3 or 5 days Hamamatsu Photonics ORCA-ER camera. H129 viral labeling was scored using a three point scale: + 238 = 1 to 2 cells in an area; ++ = partial labeling of an area (i.e., more than 1 or 2 cells); +++ = moderate 239 to dense labeling throughout the area (cells and processes fill most or all of the area) ( Table 1) . has relatively larger cell bodies than the adjacent NTS, will not be zero. Body weights were slightly 259 reduced (percentage of pre-surgery weight) in the vagotomized condition compared to sham-260 operated controls at six days after surgery, and before the first emesis test [-6 .9 ± 1.2 % compared to 261 -2.0 ± 1.5 %, respectively; t(14) = 2.2, p < 0.03]; but the groups displayed amount identical increases 262 in body weight by the time of tissue collection, one week after the last emesis test (7.4 ± 1.9 % 263 compared to 7.2 ± 1.2 %, respectively). (Table 1) , whereas 6 shrews displayed no detectable labeling. All shrews were 288 asymptomatic on the day of euthanization, and the percentage change in body weight was not 289 significantly different between shrews with (-7.7 ± 1.6 %) or without central viral labeling (-8.9 ± 2.3 290 %).
291
Viral immunoperoxidase labeling appeared bilaterally in the brain. Interestingly, viral labeling 292 was more prevalent in shrews euthanized at 5 days versus 9 days post-injection (Table 1 ). This (Table 1 and Fig. 10 ), whereas no preganglionic sympathetic neurons 299 were labeled in the intermediolateral cell column. In the midbrain, labeled cells appeared in the medial and lateral PBN and adjacent levels of the cerebellum (Fig. 10 and Control rats were euthanized either three days (n=2) or four days (n=4) after H129 virus was 312 injected into the ventral stomach wall. Only three of these six rats displayed viral labeling within the 313 central nervous system. All rats were asymptomatic before tissue collection and the percentage 314 change in body weight was not significantly different between animals with labeling (-3.1 ± 3.6 %) 315 versus those without labeling (+0.3 ± 3.6 %). One rat had sparse labeling confined to the NTS. The 316 other two rats displayed strong labeling of the NTS, AP, DMN, reticular formation, and spinal cord 317 (Fig. 6, 7, 8, and 9) . One of these two animals also displayed viral labeling within the PVN, SON, 318 central amygdala, BNST, and insular cortex, which was consistent with a previous report (37). (Table 1) , whereas 2 shrews displayed no detectable labeling. There was more labeling at 5 324 days post-injection compared to 3 days (Table 1 ) and labeled brain areas were similar to Study 3.
Only one animal at 5 days post-injection showed one or two labeled cells in the PVN and amygdala 326 but none in the BNST or insular cortex. All shrews were asymptomatic on the day of euthanization, 327 and the percentage change in body weight was not significantly different between shrews with (7.7 ± 328 2.7 %) or without central viral labeling (14 ± 6.3 %). showing that the brainstem regions that process sensory inputs from the stomach are similar in 339 emetic and non-emetic species.
340
In prior studies using musk shrews, intragastric administration of 120 mg/kg CuSO 4 was used 341 to produce a peak level of acute emesis (7, 24, 40, 54) . The current data verified that the cumulative 342 incidence of emesis was systematically escalated by increasing the dose of CuSO 4 . The 120 and 60 343 mg/kg doses of CuSO 4 generated emetic effects that were not dependent on an intact abdominal 344 vagus ( Fig. 1A and 4A) . However, the latency of emesis after CuSO 4 injections increased after (Fig. 1G) . The most robust effects of vagotomy on the reduction of CuSO 4 -353 induced emesis occurred after injection of a dose of 40 mg/kg, when the total number of emetic 354 episodes was significantly decreased (Fig. 4A) . Therefore, use of this dose could serve as the best 355 approach for investigating the vagal contribution to emesis in studies using musk shrews. Similarly, in to reach the intestinal transporters in vagotomized animals, and reach sufficient concentration in the 375 blood to affect area postrema during the time period that emesis was observed.
376
Our data indicate that H129 injection in the ventral stomach of musk shrews produces a 377 pattern of hind-and midbrain (and spinal cord) labeling that is largely similar to that reported for the 378 rat; whereas forebrain labeling appears to be much more limited in shrews compared to rats (37).
379
However, in the present study, central viral infection was present in only a subset of shrews (63%) 380 and rats (50%) after H129 injection into the ventral stomach wall. There was significant variability in 
407
These data suggest that, at least for musk shrews, the time window to observe H129 transneuronal 408 labeling is relatively narrow. There was also no difference in labeling observed between strains of 409 musk shrews.
410
Unlike the prior study in rats (37), the current study did not experimentally address whether (Table 1) . At present, testing the impact of vagotomy on viral 418 transport to the brain would require a large number of musk shrews because of the extensive 419 variability in H129 labeling observed.
420
Our results primarily highlight similarities in the GI-hindbrain axis of musk shrews and rats (21, Thus, we expected to observe transneuronal viral labeling in potentially unique regions of the shrew brainstem that might comprise neural circuits for vomiting that would be absent in rats. These results
425
are not unexpected since our approach labeled gastric vagal afferent projections to the brainstem,
426
and evidence supports the view that a lack of emesis is due to deficits in a motor output circuit and 427 not the sensory pathways from the GI tract to the brain (18). Moreover, data showing that vagotomy 428 blocks the effects of a low dose of intragastric CuSO 4 to induce emesis in musk shrews and produce 429 a CTA in rats (9) suggests that vagal sensory pathways that produce "nausea" and emesis are 
Perspectives and Significance
435
A central function of GI-vagal-brain pathways is to detect the presence of toxins in the upper 436 GI tract, and to initiate an appropriate defense; in many species, including humans, an emetic reflex 437 is activated. It is important to understand the biology of this system because it is stimulated in 438 numerous disease conditions and with a multitude of drug treatments. To date, most studies are 439 difficult to interpret because of the use of non-specific emetic stimuli that activate multiple levels of the 440 gut-brain axis (e.g., chemotherapy) and animals that lack an emetic reflex (e.g., rats and mice, 15).
441
To overcome these limitations, we used a small animal model with this reflex, musk shrew, and a 442 specific GI stimulus. The current studies indicate that a low dose of CuSO 4 , 40 mg/kg, could be used 443 to specifically activate the GI vagal afferent pathway to produce emesis in musk shrews. We also 444 demonstrate the application of vagal lesion verification in this species; this is a standard retrograde 445 tracing technique used in studies of the vagus in rats and should be applied to research studies using 446 musk shrews since abdominal vagal surgery is an important approach for investigating the emetic 447 system. We also show the value of continued use of multiple behavioral measures of emesis 448 (vomiting, emetic duration, cumulative latency, etc.) to make detailed measures of differences 
